OpenAIEventBusinessOctober 20, 2026

OpenAI acquires Orchestra Bio for life sciences R&D

Read original source →openai.com

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, aiming to help biopharma teams accelerate drug development. No financial terms were disclosed.

1 source

More stories today

Open the live feed